CP-EPS8-NLS is a peptide with anti-AML properties. It disrupts ESP8-related signaling and exhibits anti-AML activity across various AML cell types. Additionally, CP-EPS8-NLS demonstrates potent antitumor effects in xenograft tumor models. It effectively downregulates EPS8 expression along with its downstream pathways.
Target:
Complement System
TP3753
* VAT and and shipping costs not included. Errors and price changes excepted
